Work

Phase 1 first-in-human clinical study of S-trans, trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors

Year: 2009

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-009-1027-4

Authors: Apostolia Maria Tsimberidou, Michelle A. Rudek, David Hong, Chaan S. Ng, Jessica Blair, Howard Goldsweig, Razelle Kurzrock

Institutions: The University of Texas MD Anderson Cancer Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Protein Kinase Regulation and GTPase Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Johns Hopkins University

OpenAlex ID: W2018958796

FWCI: 2.547

Cites: 28

Cited by: 46

Related to: 10